● Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Condition: Locally Advanced Head and Neck Squamous Cell Carcinoma · Sponsor: AstraZeneca

PhasePhase 3

Planned participants1145

Who can joinAll sexes, 18 Years to 130 Years

Healthy volunteersNo

About this study

The main purpose of this study is to assess the efficacy and safety of volrustomig compared to observation in participants with unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) who have not progressed after receiving definitive concurrent chemoradiotherapy (cCRT).

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (306)

Research Site	Birmingham, Alabama, United States	Recruiting
Research Site	Phoenix, Arizona, United States	Recruiting
Research Site	Prescott Valley, Arizona, United States	Recruiting
Research Site	Springdale, Arkansas, United States	Withdrawn
Research Site	Fountain Valley, California, United States	Recruiting
Research Site	Los Angeles, California, United States	Recruiting
Research Site	Orange, California, United States	Withdrawn
Research Site	San Francisco, California, United States	Recruiting
Research Site	Santa Rosa, California, United States	Recruiting
Research Site	Whittier, California, United States	Recruiting
Research Site	Aurora, Colorado, United States	Recruiting
Research Site	Colorado Springs, Colorado, United States	Recruiting

+ 294 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06129864